Tacrolimus Therapy

Tacrolimus Therapy is a pharmacological treatment modality within calcineurin inhibitor therapy that specifically employs tacrolimus, a potent immunosuppressive agent, to selectively inhibit calcineurin-mediated T-cell activation for the prevention of organ transplant rejection.

3K

Publications

138.3K

Citations

15K

Authors

2.7K

Institutions

Publications per year

2017–2026

592

Authors

15K

  1. JJ
    John J. Fung

    University of Pittsburgh, United States

    49 publications · 3.3K citations

    30

    h-index

  2. DK
    Dirk Kuypers

    KU Leuven, Belgium

    33 publications · 2.7K citations

    24

    h-index

  3. LR
    Lionel Rostaing

    Hôpital Rangueil, France

    32 publications · 2.5K citations

    23

    h-index

  4. DA
    Dennis A. Hesselink

    Erasmus MC, Netherlands

    35 publications · 1.7K citations

    22

    h-index

  5. TE
    Thomas E. Starzl

    University of Pittsburgh, United States

    31 publications · 2.3K citations

    22

    h-index

1–5 of 15K

Venues

  1. Transplantation

    298 publications · 22.6K citations

    86

    h-index

  2. American Journal of Transplantation

    153 publications · 13.4K citations

    73

    h-index

  3. Transplantation Proceedings

    295 publications · 7.1K citations

    37

    h-index

  4. PubMed

    Repository · 126 publications · 5K citations

    35

    h-index

  5. Therapeutic Drug Monitoring

    93 publications · 3.9K citations

    34

    h-index

1–5